Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fink

Showing results (51-60 of 418) with videos related to

Pageof 42
Sort By:
Current Opinion in Critical Care|July 20, 2004
Research: advances in cell biology relevant to critical illnessMitchell P Fink
Critical Care Medicine|June 1, 1995
Another negative clinical trial of a new agent for the treatment of sepsis: rethinking the process of developing adjuvant treatments for serious infectionsM P Fink
Critical Care Medicine|June 1, 1997
The flow-directed, pulmonary artery catheter and outcome in critically ill patients: have we heard the last word?M P Fink
Nursing Times|March 22, 1979
Victims of political-racial persecutionK P Fink
Critical Care Medicine|May 19, 2009
Peroxisome proliferator activator receptor gamma (PPARgamma) agonists as therapeutic adjuncts in critical illness: efficacy might be suboptimal in elderly patientsMitchell P Fink
Journal of Leukocyte Biology|August 1, 2009
Editorial: Hemopexin: newest member of the anti-inflammatory mediator clubMitchell P Fink
Critical Care (London, England)|October 2, 2007
Bench-to-bedside review: High-mobility group box 1 and critical illnessMitchell P Fink
The Journal of Surgical Research|May 11, 2010
The therapeutic potential of pyruvateMitchell P Fink
Critical Care (London, England)|June 16, 2004
Pathophysiology of intensive care unit-acquired anemiaMitchell P Fink
Current Opinion in Anaesthesiology|April 30, 2008
Ethyl pyruvateMitchell P Fink
Pageof 42

Showing results (51-60 of 418) with videos related to

Sort By:
Pageof 42
Current Opinion in Critical Care|July 20, 2004
Research: advances in cell biology relevant to critical illnessMitchell P Fink
Critical Care Medicine|June 1, 1995
Another negative clinical trial of a new agent for the treatment of sepsis: rethinking the process of developing adjuvant treatments for serious infectionsM P Fink
Critical Care Medicine|June 1, 1997
The flow-directed, pulmonary artery catheter and outcome in critically ill patients: have we heard the last word?M P Fink
Nursing Times|March 22, 1979
Victims of political-racial persecutionK P Fink
Critical Care Medicine|May 19, 2009
Peroxisome proliferator activator receptor gamma (PPARgamma) agonists as therapeutic adjuncts in critical illness: efficacy might be suboptimal in elderly patientsMitchell P Fink
Journal of Leukocyte Biology|August 1, 2009
Editorial: Hemopexin: newest member of the anti-inflammatory mediator clubMitchell P Fink
Critical Care (London, England)|October 2, 2007
Bench-to-bedside review: High-mobility group box 1 and critical illnessMitchell P Fink
The Journal of Surgical Research|May 11, 2010
The therapeutic potential of pyruvateMitchell P Fink
Critical Care (London, England)|June 16, 2004
Pathophysiology of intensive care unit-acquired anemiaMitchell P Fink
Current Opinion in Anaesthesiology|April 30, 2008
Ethyl pyruvateMitchell P Fink
Pageof 42